Prestige Consumer Healthcare financials
$46.74−0.40%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY26 Mar 31 | FY25 Mar 31 | FY24 Mar 31 | FY23 Mar 31 | FY22 Mar 31 | FY21 Mar 31 | FY20 Mar 31 | FY19 Mar 31 | FY18 Mar 31 | FY17 Mar 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.09B | $1.14B | $1.13B | $1.13B | $1.09B | $943.4M | $963.0M | $975.8M | $1.04B | $882.1M |
| Gross profit | $595.6M | $634.5M | $624.4M | $625.3M | $620.6M | $547.5M | $552.2M | $555.6M | $576.5M | $500.3M |
| Gross margin | 54.7% | 55.8% | 55.5% | 55.4% | 57.1% | 58.0% | 57.3% | 56.9% | 55.4% | 56.7% |
| Operating income | $309.4M | $336.8M | $342.4M | -$22.4M | $329.9M | $297.4M | $291.2M | $66.2M | $215.5M | $257.5M |
| Net income | $190.3M | $214.6M | $209.3M | -$82.3M | $205.4M | $164.7M | $142.3M | -$35.8M | $339.6M | $69.4M |
| Net margin | 17.5% | 18.9% | 18.6% | −7.3% | 18.9% | 17.5% | 14.8% | −3.7% | 32.6% | 7.9% |
| Diluted EPS | $3.91 | $4.29 | $4.17 | $-1.65 | $4.04 | $3.25 | $2.78 | $-0.69 | $6.34 | $1.30 |
| EBITDA | $340.7M | $379.4M | $373.1M | $380.4M | $363.1M | $330.0M | $320.1M | $327.5M | $348.8M | $283.3M |
| Operating cash flow | $257.6M | $251.5M | $248.9M | $229.7M | $259.9M | $235.6M | $217.1M | $189.3M | $210.1M | $147.8M |
| Free cash flow | $246.4M | $243.3M | $239.4M | $221.9M | $250.3M | $213.4M | $202.6M | $178.8M | $197.6M | $144.8M |
| Diluted shares | 48.7M | 50.1M | 50.2M | 49.9M | 50.8M | 50.6M | 51.1M | 52.1M | 53.5M | 53.4M |
Balance sheet
| Period end | Mar 31 | Mar 31 | Mar 31 | Mar 31 | Mar 31 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $63.9M | $97.9M | $46.5M | $58.5M | $27.2M | $32.3M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $1.01B | $1.02B | $1.13B | $1.35B | $1.48B | $1.49B |
| Total assets | $3.49B | $3.40B | $3.32B | $3.35B | $3.67B | $3.43B |
| Total liabilities | $1.61B | $1.57B | $1.66B | $1.91B | $2.09B | $2.07B |
| Shareholders' equity | $1.89B | $1.83B | $1.66B | $1.45B | $1.58B | $1.36B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology